Brian Schlain

1.3k total citations
17 papers, 918 citations indexed

About

Brian Schlain is a scholar working on Electrical and Electronic Engineering, Oncology and Statistics, Probability and Uncertainty. According to data from OpenAlex, Brian Schlain has authored 17 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Electrical and Electronic Engineering, 5 papers in Oncology and 4 papers in Statistics, Probability and Uncertainty. Recurrent topics in Brian Schlain's work include Full-Duplex Wireless Communications (5 papers), Polyomavirus and related diseases (5 papers) and Biosimilars and Bioanalytical Methods (3 papers). Brian Schlain is often cited by papers focused on Full-Duplex Wireless Communications (5 papers), Polyomavirus and related diseases (5 papers) and Biosimilars and Bioanalytical Methods (3 papers). Brian Schlain collaborates with scholars based in United States. Brian Schlain's co-authors include Meena Subramanyam, Tatiana Plavina, Melissa Berman, Barry Ticho, Sophia Lee, Gary Bloomgren, Shibeshih Belachew, Denise I. Campagnolo, Sandra Richman and Ted Yednock and has published in prestigious journals such as Annals of Neurology, Clinical Chemistry and Statistics in Medicine.

In The Last Decade

Brian Schlain

17 papers receiving 879 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Schlain United States	9	634	473	303	150	112	17	918
James Scanlon United States	9	594 0.9×	573 1.2×	231 0.8×	104 0.7×	150 1.3×	14	1.4k
Anke Vennegoor Netherlands	17	501 0.8×	524 1.1×	184 0.6×	67 0.4×	142 1.3×	24	824
Melissa Berman United States	5	390 0.6×	247 0.5×	215 0.7×	93 0.6×	55 0.5×	7	489
Sylvia Pasternak Canada	16	383 0.6×	128 0.3×	198 0.7×	41 0.3×	32 0.3×	42	783
Troy Tompkins United States	9	331 0.5×	91 0.2×	231 0.8×	87 0.6×	17 0.2×	13	522
Tuan Dong‐Si Germany	10	182 0.3×	172 0.4×	86 0.3×	46 0.3×	87 0.8×	14	517
Dustin Holloway United States	12	298 0.5×	35 0.1×	125 0.4×	57 0.4×	19 0.2×	16	717
Benjamin A. Wood Australia	19	324 0.5×	153 0.3×	31 0.1×	11 0.1×	33 0.3×	90	894
Anna Kordelia Kurz Germany	15	712 1.1×	20 0.0×	304 1.0×	113 0.8×	15 0.1×	26	978
Michael G. E. OʼRourke Australia	14	496 0.8×	30 0.1×	86 0.3×	13 0.1×	22 0.2×	30	838

Countries citing papers authored by Brian Schlain

Since Specialization

Citations

This map shows the geographic impact of Brian Schlain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Schlain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Schlain more than expected).

Fields of papers citing papers by Brian Schlain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Schlain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Schlain. The network helps show where Brian Schlain may publish in the future.

Co-authorship network of co-authors of Brian Schlain

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Schlain. A scholar is included among the top collaborators of Brian Schlain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Schlain. Brian Schlain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Yeung, David T, et al.. (2016). Evaluation of highly sensitive immunoassay technologies for quantitative measurements of sub-pg/mL levels of cytokines in human serum. Journal of Immunological Methods. 437. 53–63. 50 indexed citations

Plavina, Tatiana, Meena Subramanyam, Gary Bloomgren, et al.. (2014). Anti–JC virus antibody levels in serum or plasma further define risk of natalizumab‐associated progressive multifocal leukoencephalopathy. Annals of Neurology. 76(6). 802–812. 306 indexed citations

Lee, Peter P., Tatiana Plavina, Albert Castro, et al.. (2013). A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. Journal of Clinical Virology. 57(2). 141–146. 126 indexed citations

Plavina, Tatiana, et al.. (2012). An enhanced ELISA for detection of anti-JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification. 3. 1 indexed citations

Plavina, Tatiana, Melissa Berman, Mary Crossman, et al.. (2011). Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma. Journal of Clinical Virology. 53(1). 65–71. 17 indexed citations

Shapiro, Reneé, Tatiana Plavina, Brian Schlain, et al.. (2011). Development and validation of immunoassays to quantify the half-antibody exchange of an IgG4 antibody, natalizumab (Tysabri®) with endogenous IgG4. Journal of Pharmaceutical and Biomedical Analysis. 55(1). 168–175. 28 indexed citations

Gorelik, Leonid, Michaela Lerner, Sarah A. Bixler, et al.. (2010). Anti‐JC virus antibodies: Implications for PML Risk Stratification. Annals of Neurology. 68(3). 295–303. 326 indexed citations

Schlain, Brian, et al.. (2009). A novel gamma-fitting statistical method for anti-drug antibody assays to establish assay cut points for data with non-normal distribution. Journal of Immunological Methods. 352(1-2). 161–168. 10 indexed citations

Davenport, James M. & Brian Schlain. (2000). Testing Claimed Minimal Detectable Concentrations of in Vitro Medical Diagnostic Devices. Clinical Chemistry. 46(10). 1669–1680. 3 indexed citations

10.

Schlain, Brian. (1998). A stochastic approximation method for assigning values to calibrators. Clinical Chemistry. 44(4). 839–848. 1 indexed citations

11.

Schlain, Brian. (1998). A stochastic approximation method for assigning values to calibrators.. PubMed. 44(4). 839–48. 1 indexed citations

12.

Schlain, Brian, et al.. (1996). Two-stage procedure for evaluating interassay carryover on random-access instruments. Clinical Chemistry. 42(5). 725–731. 12 indexed citations

13.

Schlain, Brian, Philip T. Lavin, & Cheryl L. Hayden. (1993). Using autoregressive and random walk models to detect trends and shifts in unequally spaced tumour biomarker data. Statistics in Medicine. 12(3-4). 265–279. 8 indexed citations

14.

Krouwer, Jan S. & Brian Schlain. (1993). A method to quantify deviations from assay linearity. Clinical Chemistry. 39(8). 1689–1693. 12 indexed citations

15.

Schlain, Brian, Philip T. Lavin, & Cheryl L. Hayden. (1992). Using an autoregressive model to detect departures from steady states in unequally spaced tumour biomarker data. Statistics in Medicine. 11(4). 515–532. 8 indexed citations

16.

Schlain, Brian & Jan S. Krouwer. (1989). Multi-factor designs. II. A design for identifying instruments with sample-to-sample carryover and drift.. PubMed. 35(10). 2118–20. 1 indexed citations

17.

Krouwer, Jan S., et al.. (1988). A multi-factor experimental design for evaluating random-access analyzers.. Clinical Chemistry. 34(9). 1894–1896. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact